![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 29202-29210, October 8, 1999
,From the Institute for Cellular and Molecular Biology and Department of Microbiology, University of Texas, Austin, Texas 78712-1064
| |
ABSTRACT |
|---|
|
|
|---|
The mouse quaking (qk)
gene is essential in both myelination and early embryogenesis. Its
product, QKI, is an RNA-binding protein belonging to a growing protein
family called STAR (signal transduction and
activator of RNA). All members have an
~200-amino acid STAR domain, which contains a single extended
heteronuclear ribonucleoprotein K homologue domain flanked by two
domains called QUA1 and QUA2. We found that QKI isoforms could
associate with each other, while one of the lethal mutations
qkIkt4 with a single amino acid change in QUA1
domain, leads to a loss of QKI self-interaction. This suggests that the
QUA1 domain is responsible for QKI dimerization. Three QKI isoforms
have different carboxyl termini and different subcellular localization.
Here, using GFP fusion protein, we identified a 7-amino acid novel
nuclear localization sequence in the carboxyl terminus of QKI-5, which is conserved in a subclass of STAR proteins containing SAM68 and ETLE/T-STAR. Thus, we name this motif STAR-NLS. In addition, the effects of active transcription, RNA-binding and self-interaction on
QKI-5 localization were analyzed. Furthermore, using an interspecies heterokaryon assay, we found that QKI-5, but not another STAR protein
ETLE, shuttles between the nucleus and the cytoplasm, which suggests
that QKI-5 functions in both cell compartments.
QKI1 is a KH-type
RNA-binding protein that has been identified as the product of the
mouse quaking (qk) locus (1).
qkv, the original viable allele described by
Sidman (2) is a recessive dysmyelination mutation that affects the
nervous system globally. Mutant mice start to have tremors on day 11 after birth and develop seizures as they mature. There are also several
ethylnitrosourea-induced mutations to qk
(qkenu), but surprisingly, these are all early
embryonic lethals (3). These mutations, along with the recent knockout
of quaking,2
demonstrate that this locus is pleiotropic, affecting diverse systems
and implying that it defines some fundamental process employed by many tissues.
QKI, along with germ line-deficient (GLD-1) from
Caenorhabditis elegans and the mammalian cell signaling
protein SAM68, defines a large, evolutionarily conserved, extended KH
domain family of proteins called STAR (signal
transduction and activator of RNA) (1, 4). STAR proteins also contain two new domains immediately flanking
the KH domain, QUA1 and QUA2, for which no function has yet been
assigned (Fig. 1). All of the STAR proteins studied have been shown to
bind RNA (5-7) and some to self-associate (5, 8); however, to date,
there is experimental evidence for a role in cell signaling only for
SAM68 (9). This is implied for some other family members from sequence
motifs such as proline-rich regions containing potential Src homology
3-binding sites and a carboxyl tail rich in tyrosine residues.
Where mutants exist, the STAR proteins display many interesting
phenotypes. The Drosophila qkI homologue how/who
is involved in muscular function and larval development since some
mutations are flightless and others are larval lethals (10-12). Some
alleles of C. elegans gld-1 have an overgrowth of mitotic
oocytes, whereas others have non-essential effects on male fate
specification in the hermaphrodite germ line (13). Mammalian splicing
factor 1 (SF1/ZMF1) is the homologue of Bbp1, the only STAR family
member in yeast, which is a component of the pre-splicing complex (7, 14).
In the rapidly growing STAR family, other members include several QKI
homologs identified in frog (15), chicken (16), zebrafish (17), and
human (GenBank AL031781). Recently, two genes similar to SAM68 were
cloned: étoile/T-STAR/slm-2 and
slm-1 (18, 19). In Drosophila, which has been
studied by degenerate PCR, there are at least nine STAR family members
(20); in C. elegans, where the sequence is complete, using
BLAST, there are eight good matches to the STAR domain.
The mouse qkI locus produces a diverse set of proteins by
alternative splicing (21). The first three studied in any detail (QKI-5, -6, and -7) appear to have different roles in development. They
are constructed with the same 311-amino acid body but have different
carboxyl tails consisting of 30, 8, and 14 amino acids, respectively.
QKI-5 is prominently expressed in early embryogenesis, and the
abnormality of QKI-5enu is therefore believed to be
responsible for the lethality of qkenu embryos
around 9.5 days of gestation. In contrast, QKI-6 and -7 are only
detectable by Northern blots in late development when myelination
starts in earnest. Their very low expression in myelinating glia is
believed to be responsible for the qkv phenotype
(1, 22).
Using antibodies specific for each carboxyl tail, Hardy et
al. (22) showed that in mouse brain, all three isoforms are
expressed in glial cells. Remarkably, QKI-5 is nuclear whereas QKI-6
and -7 are predominantly cytoplasmic (22). Since the only difference in
these proteins is their carboxyl tail, the 30-amino acid QKI-5 tail
might be responsible for nuclear localization, although there is no
classical basic nuclear localization signal (NLS) (23, 24). However,
the localization study of Xenopus QKI (XQUA), which is 94%
identical to QKI-5, showed some differences. Using a Xenopus
oocyte injection assay, XQUA was shown to be present in both the
nucleus and the cytoplasm (5). In addition, in the mouse embryo, it was
found that in a subset of migrating neural progenitors that later
differentiate into glial cells, QKI-5 was redistributed from the
nucleus to the cytoplasm (25). Thus, QKI-5 may function in both the
nucleus and cytoplasm and may, in fact, shuttle between them.
In this study, we investigated the dynamic localization of QKI-5 using
green fluorescent protein (GFP) as a reporter. Furthermore, the effects
of self-interaction, RNA binding, and active transcription on its
nuclear localization were also studied. The results show that the
30-amino acid carboxyl tail is necessary and sufficient for its nuclear
localization and contained within it is a 7-amino acid novel nuclear
localization sequence we name STAR-NLS. The same NLS is used by SAM68
and T-STAR/ETLE. However, using an interspecies heterokaryon assay, we
find that, unlike T-STAR/ETLE, QKI-5 shuttles between the nucleus and
cytoplasm in a transcription-dependent manner.
Plasmid Constructions--
The in vitro expression
constructs pTkozQKI-5 and pTkozQKI-5kt4 were generated by
inserting the entire coding region of QKI-5 or QKI-5kt4
with a Kozak start sequence into the BglII/EcoRV
sites of the in vitro expression vector pT7Ts (26). The
QKI-5 coding region was inserted in frame into the
EcoRI/SalI site of pET28a+ (Novagen) to generate
the clone pET28QKI-5 for bacterial expression. To generate the yeast
two-hybrid assay constructs, the QKI isoforms and QKI-5kt4
were inserted in frame into the EcoRI/SalI sites
of pBTM116 (a kind gift from Dr. S. M. Hollenberg, Fred Hutchinson
Cancer Research Center, Seattle, WA) or NcoI/SacI
site of pACTII (CLONTECH). The subsequent QKI
deletion constructs were made by PCR and cloned into the
EcoRI site of the vectors. The primers used are:
STAR1 (CATGGTCGGGGAAATGGAA) and QKCT (ATAACACACCACTGGGTTC) for
QKI-body; 5kb1 (CCGGTGCGGTGGCTACTAAAG) and 5kb2 (TGTTGCCGGTGGCGGCTC)
for QKI-5tail. pBTM116-Lamin (kindly provided by Dr. S. M. Hollenberg, Fred Hutchinson Cancer Research Center, Seattle, WA) and
pTD1-1 (pACTII-T-antigen) (CLONTECH) were used as
negative control for yeast two-hybrid assay.
To generate GFP fusion constructs, the QKI entire coding region and a
series of mutated fragments: QKI-body, QKI-5kt4, and
QKI-5tail, were cloned in frame into the mammalian expression vector
pEGFP-C1 (CLONTECH). The fusion proteins have GFP
at the NH2 terminus. The GFP-NLS fusion constructs were
generated by annealing three sets of two oligos: NLS1
(AATTCCCGTGTCCATCCTTACCAAAGGG) and NLS2 (GATCCCCTTTGGTAAGGATGGACACGGG)
for QKI-5-NLS; SAM68-NLS1 (AATTCCAGAGAGCATCCATATGGACGTG) and SAM68-NLS2
(GATCCACGTCCATATGGATGCTCTCTGG) for SAM68-NLS; ETLE-NLS1
(AATTCCAGAGACCAGCCATATGGCAGAG) and ETLE-NLS2 (GATCCTCTGCCATATGGCTGGTCTCTGG) for ETLE-NLS, and cloned into the EcoRI/BamHI site of pEGFP-C1. The QuickChange
site-directed mutagenesis kit (Stratagene) was used to mutate amino
acids Y to F or R to A. GFP-QKI-5 Yeast Two-hybrid Assay--
The pBTM116QKI and pACTIIQKI
constructs were cotransformed in different combinations into yeast
strain L40 (28), followed by 2 days of incubation at 30 °C on the
selective plate lacking tryptophan and leucine. At least six
independent colonies were restreaked on another plate, and the X-gal
filter assay (29) was used to determine the LacZ level of these
transformants. Colonies turned blue within 2 h were considered positive.
In Vitro Coimmunoprecipitation--
The bacterial expression
construct pET28QKI-5 was transformed into Escherichia coli
BL21 DE3 cells. A culture of 0.6 (A600) was
induced by adding isopropyl-1-thio-
The 35S-labeled QKI proteins were produced by in
vitro translation. The pTkozQKI-5 or pTkozQKI-5kt4 was
in vitro transcribed and translated using TNT coupled
reticulocyte lysates system (Promega). One fifth of the reactions were
mixed with 0.2 µg of His-tagged QKI-5 protein and mouse anti-6×His
monoclonal antibody (CLONTECH) in the IP buffer (50 mM Tris·HCl, 150 mM NaCl, 5 mM
MgCl2, 1 mM EDTA, 0.25% Nonidet P-40, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, pH 7.5). The mixture was incubated at 4 °C overnight and
precipitated by adding protein A-agarose beads (Santa Cruz
Biotechnology). Luciferase was used as a negative control. After four
washes with IP buffer, the precipitated proteins were resolved on a
10% SDS-PAGE gel and visualized by fluorography.
Cell Culture and Transfection--
HeLa (human epithelial
carcinoma cell), COS7 (green monkey kidney cell), and NIH3T3 (mouse
embryonic fibroblast cell) cells were used in the study. Cells were
grown in Dulbecco's modified Eagle's medium supplemented with 10%
fetal bovine serum at 37 °C with 5% CO2. For
microscopy, cells were grown in Lab-Tek chamber slides (Nunc) and were
transfected with plasmid DNA using SuperFect reagent (Qiagen) or Fugene
6 (Roche Molecular Biochemicals) according to manufacturer's
instruction. The transcription inhibition assay was done as described
elsewhere (30). The treatment conditions were 5 µg/ml actinomycin D
along with 20 µg/ml cycloheximide for 3 h.
Western Blot Analysis--
The same amount of cells or
transfected cells (~1 × 104) was suspended in 20 µl of Laemmli buffer and boiled for 5 min, run on 10% SDS-PAGE gels,
and transferred to polyvinylidene difluoride membranes (Millipore). The
primary antibody, rabbit anti-QKI-5 polyclonal antibody (22), was used
at a 1:5000 dilution. The secondary antibody was horseradish
peroxidase-conjugated donkey anti-rabbit IgG (Amersham Pharmacia
Biotech). Blots were visualized with ECL (Amersham Pharmacia Biotech).
Fluorescence Microscopy--
Indirect immunofluorescence was
used to show endogenous QKI-5, Surf-6 and transfected Flag-QKI-5,
myc-tagged hnRNP A1, and hnRNP C1. Cells were fixed with 4%
paraformaldehyde for 20 min and permeabilized with 0.5% Triton X-100
for 15 min. The fixed cells were then incubated with blocking solution
containing 3% bovine serum albumin and 0.2% fish gelatin in
phosphate-buffered saline for 15 min. After three washes with
phosphate-buffered saline, they were probed with primary antibody
diluted in blocking solution for 1 h at room temperature, 1:2000
for rabbit anti-QKI-5 polyclonal antibody, 1:100 for rabbit anti-mouse
Surf-6 antibody (kindly provided by Dr. C. Magoulas, Imperial Cancer
Research Fund, London, United Kingdom), 1:360 for mouse anti-Flag
monoclonal antibody (Sigma) and 1:10 for mouse anti-myc monoclonal
antibody (kindly provided by Dr. J. Fisher, University of Texas,
Austin, TX). Biotinylated goat anti-rabbit IgG or goat anti-mouse IgG (Vector) was used as secondary antibody, and Texas red-conjugated streptavidin (Vector) was used to visualize the structure. Finally, cells were stained with 50 ng/ml DAPI or 5 µg/ml Hoechst 33258 for 15 min and observed on an Axioplan fluorescence microscope (Zeiss) with a
40× plan-NeoFluar objective. To observe GFP fusion proteins, cells
were fixed with 4% paraformaldehyde 24 h after the transfection
of GFP constructs, then stained with DAPI (50 ng/ml) or Hoechst 33258 (5 µg/ml).
Heterokaryon Assays--
Interspecies heterokaryons of HeLa and
mouse NIH3T3 cells were formed as described elsewhere (31). Briefly,
HeLa cells were transfected with GFP constructs, pCMV4-Flag-QKI-5,
pcDNA3-myc-hnRNP A1, or pcDNA3-myc-C1 for 24 h, followed
by adding equal amount of untransfected mouse NIH3T3 cells. The
co-culture was incubated for 2.5 h in the presence of 75 µg/ml
cycloheximide and 30 min in 100 µg/ml cycloheximide. After being
fused with 50% polyethylene glycol 3350 for 2 min, cells were washed
and incubated in medium containing 100 µg/ml cycloheximide for
another 4 h, followed by fixation and observation described above.
Data Base Search--
The 30-amino acid QKI-5 tail, the last 23 amino acids of SAM68, and the last 23 amino acids of ETLE were used to
search the current protein data base using BLASTP program (32). The
setting of expectation was 1000, and no filter was used. All other
parameters used are default settings. Among the hits, significant
similarities were selected by eye.
The QUA1 Domain of QKI Is Responsible for
Self-interaction--
QKIkt4 was the first of the four
QKIenu mutations to have its molecular defect identified.
It has a missense change from glutamic acid to glycine at position 48 in the QUA1 domain. However, the function of QUA1 domain and the
molecular process that the mutation disrupts were unknown.
The study of XQUA and mouse QKI-7 have suggested that QKI can form
homodimers and that RNA binding is not necessary for its self-association (5, 8). However, it is not clear which domain is
responsible for oligomerization. We used the yeast two-hybrid assay to
further study QKI protein interaction. QKI isoforms, deletion
fragments, and QKI-5kt4 (Fig.
1) were fused with either LexA
DNA-binding domain or GAL4 activation domain, and then cotransformed
into yeast in different combinations (Fig.
2A). The X-gal assay shows
that all three QKI isoforms can interact with each other; in contrast,
the QKI-5kt4 mutation cannot interact with any of the QKI
isoforms. pBTM116-Lamin and pACTII-T-antigen were used as negative
control. QKI-5kt4 was chosen for this analysis as opposed
to QKI-6 or QKI-7 mutation because QKI-5 is the dominant form expressed
in the embryo, and we were interested in the isoform prevalent in
development.
To confirm that QKI-5kt4 proteins have lost their
self-interaction ability, we performed in vitro
coimmunoprecipitation experiments (Fig. 2C). His-QKI-5 was
expressed in E. coli and purified using a nickel column
(Fig. 2B). Equal amounts of in vitro translated 35S-labeled QKI-5, QKI-5kt4, or luciferase as a
negative control were mixed with purified His-QKI-5 protein. Mouse
anti-6×His monoclonal antibody was used to immunoprecipitate the
mixture and the proteins were resolved on a SDS-PAGE gel. The
co-immunoprecipitated 35S-labeled proteins were visualized
by fluorography. QKI-5 coprecipitates with His-QKI-5, while
QKI-5kt4 and luciferase do not. In vitro
translated QKI-5 only was mixed with the antibody in the
coimmunoprecipitation assay to show that it was specific (Fig.
2C, last lane).
These two experiments demonstrate that QKI isoforms can interact with
each other, but QKI-5kt4 has lost self-interaction ability;
thus, the QUA1 domain probably is responsible for the self-interaction
of QKI. To further test this hypothesis, one of the newly identified
QKI isoforms, QKI- The QKI-5 Carboxyl Tail Is Necessary and Sufficient for QKI-5
Nuclear Localization--
At the subcellular level, QKI-5 is localized
predominantly in the nucleus, while QKI-6 and QKI-7 are mostly
cytoplasmic (22). Since the only difference between the isoforms is the
carboxyl tail, it must be responsible for the different subcellular localization.
To further analyze the subcellular localization of QKI, we used GFP. As
a first step, we analyzed endogenous QKI-5 and GFP-QKI-5 fusion protein
expression in cultured cells. Using a Western blot assay, we found that
all three cell lines studied, HeLa, NIH3T3 and COS7, express endogenous
QKI-5 (Fig. 3A). However,
there is a relatively lower level in NIH3T3 cells. Because of the
relative high transfection efficiency, COS7 cells were used to check
the GFP-QKI-5 protein expression. pEGFP-QKI-5 construct was transfected into COS7 cells and the expressed protein migrated at approximately 70 kDa as expected (Fig. 3A, first lane). In
addition, Fig. 3B shows that GFP-QKI-5 has the same
localization pattern as the endogenous protein. In HeLa cells, indirect
immunofluorescence staining with anti-QKI-5 antibody reveals that the
endogenous protein and GFP-QKI-5 are both nuclear but were excluded
from nucleoli. GFP alone is evenly distributed throughout the cell. GFP
is thus a suitable tag to study QKI localization. In NIH3T3 and COS7
cells, GFP-QKI-5 has an identical localization pattern as in HeLa cells
(data not shown). Thus, HeLa cells were used in the further
localization study.
Using GFP, the effect of the QKI-5 tail was visualized. The 30-amino
acid tail was deleted and the remainder QKI-body was fused to GFP. This
pEGFP-QKI-body was then transfected into HeLa cells. Without the tail,
the fusion protein is located predominantly in the cytoplasm (Fig.
4C), similar to GFP-QKI-7
(Fig. 4B). These experiments show that the carboxyl tail of
QKI-5 is necessary for its nuclear localization.
The next question was whether this tail alone could target the protein
to the nucleus. When it was attached to the COOH terminus of GFP and
transfected into HeLa cells, all the GFP is visualized in the nucleus
(Fig. 4D). Thus, the 30-amino acid QKI-5tail alone is also
sufficient for its nuclear localization. Interestingly, in this
experiment, it was evident that there are some concentrated dots within
the nucleus that were later shown to be nucleoli (see below for discussion).
QKI-5 Has a Novel Nuclear Localization Sequence
(NLS)--
Although the QKI-5 tail is both necessary and sufficient
for its nuclear localization, it does not contain a traditional cluster of basic amino acids or bipartite NLS (34). Upon close examination and
comparison of mouse and Drosophila QKI, we found a sequence of 7 conserved amino acids (Table I):
RVHPYQR in mouse and REHPYQR in Drosophila. In addition,
very similar sequences were located at the extreme end of SAM68 and
ETLE/T-STAR. Previous work has shown that the last 23 amino acids of
SAM68 containing these 7 amino acids are responsible for its nuclear
localization (35). In addition, in T-STAR, disruption of the last 5 amino acids, which overlaps with these 7, causes the protein to
relocate to the cytoplasm (18). We hypothesized that the 7-amino acid
consensus RXhPYQ/GR is the NLS for these STAR proteins. To
examine this, we made a construct which has only these 7 amino acids
from QKI-5 (QKI-5-NLS) fused to GFP and transfected it into HeLa cells.
Although the fusion protein is expected to be less than 30 kDa, almost all the GFP-QKI-5-NLS was detected in the nucleus (Fig. 4E).
In most of the cells, GFP-QKI-5-NLS is also concentrated in dots in the
nucleus although they are not as strong as those in pEGFP-QKI-5tail transfected cells. Thus, these 7 amino acids constitute the nuclear localization signal of QKI-5.
Next, we investigated which amino acids among the 7 are important for
the NLS function. Since SAM68 is heavily phosphorylated by Src and both
QKI-5 and SAM68 are rich in tyrosine, we thought the phosphorylation of
the tyrosine residue might affect the nuclear localization. However,
when the tyrosine was mutated to phenylalanine in QKI-5 (Fig. 1) and
the pEGFP-QKI-5Y/F was transfected into HeLa cells, the expressed
protein was still located mostly in the nucleus, with only a small
amount in the cytoplasm (Fig. 4F). So if there is
phosphorylation of this tyrosine residue, it is not necessary for the
nuclear localization. Considering that basic residues play an important
role in the classical NLS, it seemed that the 2 arginines at both ends
might be important. When these residues were both changed to alanines,
the nuclear localization of GFP-QKI-5 was abolished (Fig.
4G). Thus, these 2 arginines are necessary for nuclear
localization and the 7 amino acids represent a novel nuclear
localization signal.
Using the same method, we tested whether the slightly different
sequences in SAM68 and ETLE are also capable of directing the protein
to the nucleus. Notably, the results are somewhat different. In about
20% of the transfected HeLa cells, GFP-SAM68-NLS and GFP-ETLE-NLS are
completely in the nucleus; while in the remaining 80% cells, although
GFP proteins are concentrated in the nucleus, there is also a minor
amount of fusion protein in the cytoplasm (Fig. 4, H and
I). Possibly this is because these two NLSs are not as
strong as the QKI-5-NLS or the transport of these two NLS is cell cycle
related. Nevertheless, since most of the cells have GFP proteins more
concentrated in the nucleus than in the cytoplasm, it suggests that the
7 amino acid signals in SAM68 or ETLE have NLS function. Considering
all the data, we termed this consensus sequence (RXhPYQ/GR)
STAR-NLS.
The Requirements for Normal QKI-5 Nuclear Localization--
Both
GFP-QKI-5 and GFP-QKI-5tail are expressed in the nucleus. However,
GFP-QKI-5 was excluded from the nucleoli, while GFP-QKI-5tail locates
throughout the nucleus with some concentrated dots that appear to be
nucleoli when compared with a phase-contrast image (data not shown). To
make sure that these dots are nucleoli, mouse nucleolar matrix protein
Surf-6 was used as a marker (36). Thus, mouse NIH3T3 instead of HeLa
cells were used here. pEGFP-QKI-5tail was transfected into mouse NIH3T3
cells that were then immunostained with anti-Surf-6 antibody. In Fig.
5A, the localization of
GFP-QKI-5tail and endogenous Surf-6 in the same NIH3T3 cell is shown.
Superimposition of the two shows that QKI-5tail colocalizes with Surf-6
in the nucleoli (Fig. 5A, right panel).
Next, we analyzed what could be responsible for the normal nuclear
localization of QKI-5, and what causes the difference between it and
the localization of QKI-5tail. There are several possibilities. First,
GFP-QKI-5tail could interact with some components in nucleoli, but the
interaction is masked when the whole protein is used; second, some
other proteins in the nucleoplasm may interact with QKI-5 and prevent
it from localizing in nucleoli; and third, QKI-5 binds pre-mRNA in
the nucleoplasm and the RNA binding may be required for its exclusion
from the nucleoli. To test these possibilities, we examined whether
self-interaction and RNA binding are important for normal QKI-5 localization.
The QKI-5kt4 mutation loses the ability to self-interact;
however, it retains the ability to bind RNA (45). When GFP was fused with QKI-5kt4 and transfected into HeLa cells, the
localization of GFP-QKI-5kt4 is the same as wild type QKI-5
(Fig. 5B). Thus the self-interaction is not required for the
normal QKI-5 localization.
To determine the importance of RNA binding, we deleted the central 41 amino acids (residue 96-136) of the KH domain (Fig. 1) and fused the
remainder to GFP (GFP-QKI-5
Another factor important for the localization of some RNA-binding
proteins is active transcription by RNA polymerase II. It is known that
nuclear transport of some RNA-binding proteins such as hnRNP A1 is
transcription-dependent, while for others such as hnRNP C1,
it is transcription-independent (30). Thus, we tested whether
transcription affects the nuclear localization of QKI-5. Transcription
inhibitor actinomycin D was added to untransfected and
pcDNA3-myc-hnRNP A1 or pcDNA3-myc-hnRNP C1 (27) transfected HeLa cells. Three hours later, hnRNP A1 accumulated in the cytoplasm, while hnRNP C1 was still nuclear. Interestingly, endogenous QKI-5 was
also partly trapped in the cytoplasm (Fig. 5C). This result suggested that the nuclear transport of QKI-5 is
transcription-dependent.
QKI-5, but Not ETLE, Shuttles between the Nucleus and the
Cytoplasm--
At steady state, QKI-5 is predominantly nuclear.
However, its transcription-dependent nuclear transport
suggested its shuttling ability (39). Notable in this context is that,
during the normal embryonic neuronal cell fate decision, QKI-5 is
redistributed from the nucleus to the cytoplasm in some cells (25).
This suggests that QKI-5 may also function in the cytoplasm and shuttle
between the nucleus and the cytoplasm. Some RNA-binding proteins, such as a subset of hnRNP and SR proteins, shuttle rapidly between the
nucleus and the cytoplasm (30, 40). To test whether QKI-5 can shuttle,
we performed an interspecies heterokaryon assay (31). HeLa cells were
transfected with pEGFP-QKI-5, and 24 h later, an equal amount of
NIH3T3 cells were fused to them to form heterokaryons. When new protein
synthesis was inhibited by cycloheximide, and Hoechst 33258 was used to
distinguish the mouse and human nuclei, GFP fusion protein was observed
in the NIH3T3 cell nuclei 4 h after fusion (Fig.
6A). This indicated that in
the heterokaryons, GFP-QKI-5 must be exported from the HeLa nucleus to
the cytoplasm and then imported into the NIH3T3 cell nucleus. Thus,
QKI-5 shuttles between the nucleus and the cytoplasm. At the same time
and with the same assay, the shuttling ability of another STAR protein ETLE was tested. In contrast to QKI-5, GFP-ETLE was not seen in the
mouse NIH3T3 nucleus in human-mouse heterokaryons (Fig. 6C). Thus, ETLE does not shuttle between the nucleus and the cytoplasm, or
at least not as rapidly as QKI-5. The shuttling protein hnRNP A1 was
used as a positive control and the nonshuttling protein hnRNP C1 as a
negative control. pcDNA3-myc-hnRNP A1 and pcDNA3-myc-hnRNP C1
were transfected into HeLa cells, and both of the fusion proteins behaved appropriately in the heterokaryon assay (Fig. 6,
D and E).
Although GFP is widely used to study protein localization, there are
not many studies using it in the sensitive heterokaryon assay. At this
point, it is difficult to rule out the effect of the 27-kDa GFP
component in the shuttling assay. Thus, to corroborate the shuttling
ability of QKI-5, another smaller tag, Flag, was used to study QKI-5
shuttling with the same assay. Immunostaining with mouse monoclonal
antibody against Flag verified that Flag-QKI-5 appeared in the NIH3T3
nucleus and confirmed that QKI-5 shuttles (Fig. 6B).
We analyzed the structure of QKI-5, and found that the QUA1 domain
is likely to be the self-interaction domain responsible for homo- and
hetero-dimerization. Thus, the lethal phenotype of
qkIkt4 could be caused by a failure of
QKI-5kt4 to interact with itself or other proteins.
Recently, similar results were reported for QKI-7 (33).
The studies also show that the QKI-5 carboxyl tail contains a novel
nuclear localization sequence STAR-NLS and that normal QKI-5 nuclear
localization requires active transcription and the capacity to bind
RNA, but not self-interaction. Furthermore, we showed that QKI-5, but
not the SAM68-like protein, ETLE, shuttles between the nucleus and the cytoplasm.
STAR-NLS Is a Novel Nuclear Localization Sequence--
By deletion
analysis, we showed that the 30-amino acid QKI-5 carboxyl tail is
necessary and sufficient for QKI-5 nuclear localization. In this
fragment, a 7-amino acid novel nuclear localization sequence (RVHPYQR)
was identified. It is conserved in some other STAR proteins, such as
SAM68 and ETLE/T-STAR, and thus we named the consensus sequence
(RXhPYQ/GR) STAR-NLS. When only this peptide was fused with
GFP, it can drive the reporter protein into the nucleus.
It is of interest that some non-STAR proteins also contain this
STAR-NLS. We searched the current protein data base to identify other
proteins that may have a similar signal (Table I). Among those
identified were: Drosophila transcription factor HNF-4
homolog, Arabidopsis splicing factor RSZp21, a hypothetical
protein CEF08G2.5 from the C. elegans sequencing project,
and a nuclear polyhedrosis virus protein. From their names, it would
seem that at least three out of the four are nuclear. These four
proteins were examined for other obvious classic NLS, but none were
found. Thus, they probably use this motif for nuclear
localization. Further analysis of these proteins may reveal whether the
STAR-NLS is used outside of the STAR family.
STAR-NLS is different from not only the classical basic cluster NLS and
bipartite NLS, but also the newly defined shuttling sequence M9 of
hnRNP A1 or KNS of hnRNP K (31, 41). M9 and KNS are responsible for
both nuclear import and export and these two contrasting activities
appear to be inseparable (31). An important question is which pathway
is used to import STAR-NLS containing proteins. Import of the classical
NLS is mediated by the importin The Significance of QKI-5 Shuttling--
The finding that QKI-5
shuttles between the nucleus and the cytoplasm expands our
understanding of the possible function of QKI. Of the three well
studied isoforms, QKI-5 is predominantly nuclear, while QKI-6 and QKI-7
are mostly cytoplasmic. The simplest interpretation suggests that QKI-5
functions in the nucleus, while the others function mostly in the
cytoplasm. The shuttling of QKI-5 makes the scenario more complex; it
means that QKI-5 might also function in the cytoplasm. Furthermore, QKI
isoforms can associate with each other. Their heterodimerization in
either the nucleus or the cytoplasm would let QKI fine tune its
function. An important role for shuttling proteins is transporting RNA, and in this sense, the QKI isoforms could function as a relay team.
QKI-5 might escort a specific group of RNAs out of the nucleus, while
QKI-6 and QKI-7 would continue to interact with them in the cytoplasm.
QKI-5 could then be recycled back to the nucleus. Similar to a group of
RNA binding proteins like hnRNP A1, the reimport of QKI-5 into the
nucleus is transcription dependent. A second consequence of shuttling
might be carrying cell signals from the cytoplasm into the nucleus.
Interestingly, another STAR protein ETLE does not shuttle, or its
shuttling is so slow that it is not detectable in our assay. This is
surprising because QKI-5 and ETLE use the same STAR-NLS. This
difference in their ability to shuttle suggests that there are other
sequence elements besides STAR-NLS involved. SAM68 is very close in
sequence to ETLE; therefore, it will be interesting to determine
whether SAM68 and other STAR proteins also shuttle.
For QKI-5, it will also be important to determine what is responsible
for its shuttling/export. There are two leucine-rich regions similar to
the classical nuclear export sequence in the QUA1 and QUA2 domains,
(34). One or both of them could be responsible for the export of QKI-5,
but it is also possible that QKI-5 could use another, unidentified
export sequence. The balance between export and import signals may be
responsible for changes in the localization of QKI-5 at different
developmental stages, such as, has been found in fetal mouse brain
(25).
Speculations about QKI Function--
STAR proteins use the same
RNA-binding motif, but they have different localizations and diverse
functions. In addition, most of the STAR proteins are extensively
alternatively spliced, generating even more variation. This variation
could permit a diversity of molecular functions. For example, SF1/ZFM1
is reported to bind the branch point in the introns of pre-mRNA and
function as a pre-splicing factor (7, 14). However, it can also
interact with transcription activator SSAP and repress transcription
(43). Another family member from C. elegans, GLD-1, which is
solely cytoplasmic, has recently been shown to repress translation of specific mRNAs by binding to the tra-2 and
GLI elements (TGE) in their 3'-untranslated
region (44). Likewise, QKI-6 has been found to have the same function
in transgenic C. elegans (45). Finally, SAM68 has been
recently shown to substitute for HIV-1 Rev protein in facilitating the
nuclear export of HIV-1 RNA (46).
With respect to QKI, the mutations make it clear that it is important
in myelination and early development. However, the role of QKI in RNA
metabolism and, if any, in signal transduction, is not clear. Relevant
are the studies that show, in qkv mutant mice,
some gene products are altered at the RNA level (47); myelin-associated
glycoprotein has a changed ratio of alternative splice products (48),
and the myelin basic protein mRNA level is low in mouse brain at
the peak of myelination but becomes normal later (49). QKI is most
likely responsible for these alterations.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
KH was made by PCR using the
primer dKH1 (ATCAGGGTATTCTTTTACAGGCAC) and dKH2
(GAGGAGCAAAATAGAGGCAAGCCC) and pEGFP-QKI-5 as template. ETLE
coding region was obtained by PCR from original cDNA and subcloned
into the TA cloning vector PCR2.1 (Invitrogen). An
ETLE-EcoRI fragment was inserted in frame into pEGFP-C1
vector. FLAG-QKI-5 was made by inserting QKI-5 coding region in frame
into pCMV4 vector (Eastman Kodak Co.). pcDNA3-myc-hnRNP-A1 and
pcDNA3-myc-hnRNP C1 were kindly provided by Dr. G. Dreyfuss
(University of Pennsylvania, Philadelphia, PA) and described elsewhere
(27).
-D-galactopyranoside
to a final concentration of 1 mM. 2 h after induction,
cells were collected and broken by French press in the purification
buffer (50 mM KH2PO4, 300 mM KCl, pH 7.0, and 1 mM phenylmethylsulfonyl fluoride). After centrifugation at 12,000 × g for 15 min, the supernatant was loaded onto a Ni-NTA agarose column (Qiagen), washed extensively with purification buffer, and eluted with
purification buffer containing 300 mM imidazole.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Isoforms and mutations of QKI used in the
study. QKI has a 206-amino acid STAR domain, which contains a
single extended KH module flanked by QUA1 and QUA2 domains. Three
isoforms of QKI have different carboxyl tails, which are 30 amino acids
for QKI-5, 8 for QKI-6, and 14 for QKI-7. QKI-5kt4 has a
Glu to Gly change in the QUA1 domain. QKI-body has all the 311-amino
acid QKI common part, but not the tail. QKI-
KH contains only the
QUA1 domain and part of the KH domain (residue 1-134). QKI-5tail only
has the 30-amino acid QKI-5 carboxyl tail (residue 312-341).
QKI-5
KH is QKI-5 with 41 amino acids deleted from the middle of the
KH domain (residue 96-136). QKI-5 Y/F and QKI-5 RR/AA have amino acids
changed in the tail of QKI-5. The figure is drawn to approximate
scale.

View larger version (28K):
[in a new window]
Fig. 2.
Summary of QKI dimerization study.
A, study of QKI dimerization using yeast two-hybrid assay.
QKI isoforms and mutations were cloned into pBTM116 and pACTII to fuse
with LexA DNA-binding domain and GAL4 activation domain. They were
cotransformed into yeast strain L40 in different combinations, and
X-gal assays were performed to measure interaction. pBTM116-Lamin and
pACTII-T-antigen were used as negative control. Blue colonies are
indicated by (+), and white by (
). B, purification of
6×His-tagged QKI-5 protein (His-QKI-5). pET28QKI-5 was transformed
into E. coli BL21 DE3 cells. Protein His-QKI-5 was produced
and purified as indicated under "Experimental Procedures." Crude
lysate and purified protein were run on SDS-PAGE gels and stained with
Coomassie Blue. C, QKI-5kt4 does not form dimers
with QKI-5. 35S-Labeled, in vitro
translated QKI-5, QKI-5kt4, or luciferase were mixed with
0.2 µg of His-QKI-5 and immunoprecipitated with mouse anti-6×His
antibody. The precipitate was run on an SDS-PAGE gel and visualized by
fluorography. One-tenth of the input 35S-labeled proteins
were run on the same gel. QKI-5 coprecipitates with His-QKI-5, while
QKI-5kt4 and luciferase do not.
KH (21), which contains only the QUA1 domain and
part of the KH domain (residues 1-134) (Fig. 1), was used in the yeast
two-hybrid assay. The result showed that QKI-
KH is sufficient to
interact with the other QKI isoforms (Fig. 2A). These data
together strongly suggest that the QUA1 domain contains
self-interaction function. It is also noteworthy that this result
confirms a contemporary study using QKI-7 (33).

View larger version (28K):
[in a new window]
Fig. 3.
Expression and localization of QKI-5 in
tissue culture cells. A, Western blot assay of QKI-5 in
cultured cells. Equal amount of cell extracts were run on SDS-PAGE gels
and immunoblotted with rabbit anti-QKI-5 antibody. Endogenous QKI-5
runs at 38 kDa; in transfected cells, GFP-QKI-5 runs at ~70 kDa. The
bands at ~60 kDa are nonspecific. B, localization of QKI-5
in HeLa cells. GFP-QKI-5 has the same subcellular localization as
endogenous QKI-5. Indirect immunostaining using anti-QKI-5 antibody was
used to show the endogenous QKI-5 in HeLa cells. For GFP constructs,
HeLa cells were transfected with pEGFP-QKI-5 or pEGFP-C1 as control.
The transfected cells were fixed with paraformaldehyde, stained with
DAPI, and observed.

View larger version (38K):
[in a new window]
Fig. 4.
Nuclear localization of QKI-5. QKI
isoforms and mutations were fused to the COOH terminus of GFP, and the
constructs were transfected into HeLa cells. 24 h after
transfection, cells were fixed and observed. The structure of
constructs A-D, F, and G are shown in Fig. 1, while sequences of E, H,
and I are shown in Table I. QKI-5 is localized in nucleoplasm, but not
nucleoli (A). QKI-7 is located mostly in the cytoplasm
(B), and so is QKI-body, which is QKI-5 without the 30-amino
acid tail (C). The 30-amino acid carboxyl tail of QKI-5 can
target all the GFP into the nucleus, but there are some concentrated
dots (D). The 7-amino acid conserved NLS of QKI-5, guides
most of the GFP into the nucleus (E). When the Tyr in the 7 amino acids was changed to Phe in QKI-5, most of the protein is still
in the nucleus, while some patches can be seen in the cytoplasm
(F). When 2 Arg were changed to Ala, the nuclear
localization of QKI-5 is abolished (G), which has the same
effect as deleting the whole 30-amino acid tail. The SAM68 and ETLE
7-amino acid NLS have similar but not identical localizations as the
QKI-5-NLS. In some cells, they target all the GFP to the nucleus, in
about 80% of the cells, there is some GFP in the cytoplasm as well as
the nucleus (H and I).
Sequence of STAR-NLS in STAR and non-STAR proteins

View larger version (29K):
[in a new window]
Fig. 5.
Requirement for normal QKI-5
localization. A, in NIH3T3 cells, the QKI-5tail
colocalizes with nucleolar matrix protein Surf-6. Rabbit anti-mouse
Surf-6 antibody was used to show the nucleoli (middle panel), which colocalize with the GFP-QKI-5tail
(left panel) as shown by the yellow in
the superimposition of the same cell (right panel). B, the effect of self-interaction and RNA
binding on the nuclear localization of QKI-5. GFP-QKI-5,
GFP-QKI-5kt4, and GFP-QKI-5
KH were transiently
expressed in transfected HeLa cells. The localization of
GFP-QKI-5kt4, which cannot form homodimers, is the same as
normal QKI-5. GFP-QKI-5
KH has punctate nuclear structure, but is
still excluded from nucleoli. C, the effect of transcription
inhibition on QKI-5 localization. pcDNA3-myc-hnRNP A1 and
pcDNA3-myc-C1 were transfected into HeLa cells. After 24 h,
untransfected and transfected HeLa cells were treated with actinomycin
D in the presence of cycloheximide for 3 h. Rabbit anti QKI-5
antibody were used to stain untransfected cells, and endogenous QKI-5
proteins were found in both the nucleus and the cytoplasm
(left panels). myc-hnRNP A1 and myc-hnRNP C1 were
stained with mouse monoclonal anti-myc antibody. hnRNP A1 accumulated
in the cytoplasm after the inhibition of transcription
(middle panels), while hnRNP C1 stays in the
nucleus as expected (right panels).
KH). According to the previous study with
XQUA, the RNA-binding ability of this protein would be largely
abolished (5, 37). When expressed in transfected HeLa cells,
GFP-QKI-5
KH is still nuclear and excluded from the nucleoli.
Interestingly, in most of the transfected cells, there are a varying
number of punctate dots (Fig. 5B). This pattern was very
similar to that of
KH SAM68 in transfected cells (38). Thus, RNA
binding is important for the normal diffuse localization of QKI-5 in
the nucleoplasm, but it does not exclude it from the nucleoli. The
reason for the accumulation of GFP-QKI-5tail in the nucleoli remains
unknown. Alternatively, it is possible that the 30-amino acid tail or
the 7-amino acid NLS could interact with some component in nucleoli
nonspecifically. The small peptide is highly positively charged, and
thus it may interact with negatively charged rRNA or other components
in the nucleolus.

View larger version (64K):
[in a new window]
Fig. 6.
QKI-5, but not ETLE, shuttles between the
nucleus and the cytoplasm. pEGFP-QKI-5, pCMV4-FLAG-QKI-5,
pEGFP-ETLE, pcDNA3-myc-hnRNP A1, and pcDNA3-myc-hnRNP C1 were
transiently transfected into HeLa cells. 24 h after the
transfection, they were mixed with mouse NIH3T3 cells in the presence
of the translation inhibitor cycloheximide. Then, cells were fused to
form heterokaryons. Four hours after fusion, cells were fixed and
stained with anti-FLAG antibody for FLAG-QKI-5 (B) or
anti-myc antibody for myc-hnRNP A1 (D) and myc-hnRNP C1
(E). GFP-QKI-5 (A) and GFP-ETLE (C)
were observed directly under fluorescent microscope. The transfected
protein localizations are shown in left panels.
Hoechst 33258 was used to distinguish mouse and human cell nuclei
(middle panels). Phase-contrast images of the
heterokaryons are shown (right panels). The
arrows indicate the mouse nuclei within human-mouse
heterokaryons.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
complex. M9 interacts with
transportin, an importin
like protein, and uses nuclear import
machinery different from the traditional importin
/
(42), while
the nuclear import of KNS may require a third pathway (41). The
receptor for STAR-NLS is not known. Currently, we are trying to
identify proteins that interact with the QKI-5 carboxyl tail. However,
it is also possible that STAR-NLS may not bind to a nuclear
transporting receptor directly, but interact with a different protein
with an authentic NLS.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Gideon Dreyfuss for hnRNP A1 and hnRNP C1 constructs, C. Magoulas for anti-Surf-6 antibody; S. M. Hollenberg for yeast two-hybrid vectors and library, and J. Fisher for anti-myc antibody. We are also grateful to Drs. Clarence Chan and Gabriela Rennebeck for reading the manuscript.
| |
FOOTNOTES |
|---|
* This work is supported by Grants HD10668 and HD30658 from the National Institutes of Health (to K. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: School of Biomolecular and Biomedical Science,
Faculty of Science, Griffith University, Nathan, Queensland 4111, Australia.
§ Present address: University of Texas Medical School, Houston, TX 77030.
¶ To whom correspondence should be addressed: Inst. for Cellular and Molecular Biology and Dept. of Microbiology, 2500 Speedway, University of Texas, Austin, TX 78712-1064. Tel.: 512-471-1785; Fax: 512-471-2149; E-mail: artzt@uts.cc.utexas.edu.
2 T. Kaname, T. Kondo, T. Suganuma, M. Suzuki, T. Ebersole, K. Artzt, K. Yamamura, and K. Abe., submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
QKI, quaking;
hnRNP, heteronuclear ribonucleoprotein;
KH, hnRNP K homologue;
STAR, signal
transduction and activator of RNA;
NLS, nuclear localization sequence;
ETLE, étoile protein;
GLD-1, germ line-deficient;
SF1, splicing
factor 1;
GFP, green fluorescent protein;
PCR, polymerase chain
reaction;
PAGE, polyacrylamide gel electrophoresis;
HIV, human
immunodeficiency virus;
X-gal, 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside;
DAPI, 4,6-
diamidino-2-phenylindole.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ebersole, T., Chen, Q., Justice, M. J., and Artzt, K. (1996) Nat. Genet. 12, 260-265[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Sidman, R. L.,
Dickie, M. M.,
and Appel, S. H.
(1964)
Science
144,
309-311 |
| 3. | Justice, M. J., and Bode, V. C. (1988) Genet. Res. (Camb.) 51, 95-102[Medline] [Order article via Infotrieve] |
| 4. | Vernet, C., and Artzt, K. (1997) Trends Genet. 13, 479-484[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Zorn, A. M.,
and Krieg, P. A.
(1997)
Genes Dev.
11,
2176-2190 |
| 6. | Taylor, S. J., and Shalloway, D. (1994) Nature 368, 867-871[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Arning, S., Gruter, P., Bilbe, G., and Kramer, A. (1996) RNA 2, 794-810[Abstract] |
| 8. | Chen, T., Damaj, B. B., Herrera, C., Lasko, P., and Richard, S. (1997) Mol. Cell. Biol. 17, 5707-5718[Abstract] |
| 9. |
Taylor, S.,
Anafi, M.,
Pawson, T.,
and Shalloway, D.
(1995)
J. Biol. Chem.
270,
10120-10124 |
| 10. | Zaffran, S., Astier, M., Gratecos, D., and Semeriva, M. (1997) Development 124, 2087-2098[Abstract] |
| 11. | Fyrberg, C., Becker, J., Barthmaier, P., Mahaffey, J., and Fyrberg, E. (1997) Gene (Amst.) 197, 315-323[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Baehrecke, E. (1997) Development 124, 1323-1332[Abstract] |
| 13. |
Jones, A. R.,
and Schedl, T.
(1995)
Genes Dev.
9,
1491-1504 |
| 14. | Abovich, N., and Rosbash, M. (1997) Cell 89, 403-412[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Zorn, A., Grow, M., Patterson, K., Ebersole, T., Chen, Q., Artzt, K., and Krieg, P. (1997) Gene (Amst.) 188, 199-206[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Mezquita, J., Pau, M., and Mezquita, C. (1998) Mol. Reprod. Dev. 50, 70-78[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Tanaka, H., Abe, K., and Kim, C.-H. (1997) Mech. Dev. 69, 209-213[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Venables, J. P.,
Vernet, C.,
Chew, S. L.,
Cowmedow, R. B.,
Wu, J.,
Cooke, H. J.,
Artzt, K.,
and Eperon, I. C.
(1999)
Hum. Mol. Genet.
8,
959-969 |
| 19. |
Di Fruscio, M.,
Chen, T.,
and Richard, S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2710-2715 |
| 20. | Fyrberg, C., Becker, J., Barthmaier, P., Mahaffey, J., and Fyrberg, E. (1998) Biochem. Genet. 36, 51-63[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kondo, T., Furuta, T., Mitsunaga, K., Ebersole, T. A., Shichiri, M., Wu, J., Artzt, K., Yamamura, K., and Abe, K. (1999) Mamm. Genome 10, 662-669[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Hardy, R.,
Loushin, C.,
Friedrich, V.,
Chen, Q.,
Ebersole, T.,
Lazzarini, R.,
and Artzt, K.
(1996)
J. Neurosci.
16,
7941-7949 |
| 23. | Robbins, J., Dilworth, S. M., Laskey, R. A., and Dingwall, C. (1991) Cell 64, 615-623[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. E. (1984) Nature 311, 33-38[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Hardy, R. J. (1998) J. Neurosci. Res. 54, 46-57[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Krieg, P. A.,
and Melton, D. A.
(1984)
Nucleic Acids Res.
12,
7057-7070 |
| 27. |
Nakielny, S.,
and Dreyfuss, G.
(1996)
J. Cell Biol.
134,
1365-1373 |
| 28. | Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Breeden, L., and Nasmyth, K. (1985) Cold Spring Harbor Symp. Quant. Biol. 50, 643-650[Medline] [Order article via Infotrieve] |
| 30. |
Pinol-Roma, S.,
and Dreyfuss, G.
(1991)
Science
253,
312-314 |
| 31. | Michael, W. M., Choi, M., and Dreyfuss, G. (1995) Cell 83, 415-422[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402 |
| 33. |
Chen, T.,
and Richard, S.
(1998)
Mol. Cell. Biol.
18,
4863-4871 |
| 34. | Gorlich, D., and Mattaj, I. W. (1996) Science 271, 1513-1518[Abstract] |
| 35. | Ishidate, T., Yoshihara, S., Kawasaki, Y., Roy, B. C., Toyoshima, K., and Akiyama, T. (1997) FEBS Lett. 409, 237-241[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Magoulas, C., and Fried, M. (1996) DNA Cell Biol. 15, 305-316[Medline] [Order article via Infotrieve] |
| 37. |
Barlat, I.,
Maurier, F.,
Duchesne, M.,
Guitard, E.,
Tocque, B.,
and Schweighoffer, F.
(1997)
J. Biol. Chem.
272,
3129-3132 |
| 38. | McBride, A. E., Taylor, S. J., Shalloway, D., and Kirkegaard, K. (1998) Exp. Cell Res. 241, 84-95[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Pinol-Roma, S., and Dreyfuss, G. (1992) Nature 355, 730-732[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Caceres, J. F.,
Screaton, G. R.,
and Krainer, A. R.
(1998)
Genes Dev.
12,
55-66 |
| 41. | Michael, W. M., Eder, P. S., and Dreyfuss, G. (1997) EMBO J. 16, 3587-3598[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Pollard, V. W., Michael, W. M., Nakielny, S., Siomi, M. C., Wang, F., and Dreyfuss, G. (1996) Cell 86, 985-994[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Zhang, D.,
and Childs, G.
(1998)
J. Biol. Chem.
273,
6868-6877 |
| 44. | Jan, E., Motzny, C. K., Graves, L. E., and Goodwin, E. B. (1999) EMBO J. 18, 258-269[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Saccomanno, L., Loushin, C., Jan, E., Punkay, E., Artzt, K., and Goodwin, E. B. (1999) Proc. Natl. Acad. Sci. U. S. A., in press |
| 46. | Reddy, T. R., Xu, W., Mau, J. K., Goodwin, C. D., Suhasini, M., Tang, H., Frimpong, K., Rose, D. W., and Wong-Staal, F. (1999) Nat. Med. 5, 635-642[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Hardy, R. J. (1998) J. Neurosci. Res. 51, 417-422[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Fujita, N., Sato, S., Ishiguro, H., Inuzuka, T., Baba, H., Kurihara, T., Takahashi, Y., and Miyatake, T. (1990) J. Neurochem. 55, 1056-1059[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Campagnoni, A. T., Verdi, J. M., Verity, A. N., Amur-Umarjee, S., and Byravan, S. (1991) Ann. N. Y. Acad. Sci. 633, 178-188[Abstract] |
| 50. | Fumagalli, S., Totty, N. F., Hsuan, J. J., and Courtneidge, S. A. (1994) Nature 368, 871-874[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Fung, E. T., Lanahan, A., Worley, P., and Huganir, R. L. (1998) FEBS Lett. 437, 29-33[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | Zhong, W., Sladek, F. M., and Darnell, J. E., Jr. (1993) EMBO J. 12, 537-544[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H. Kuroyanagi, G. Ohno, S. Mitani, and M. Hagiwara The Fox-1 Family and SUP-12 Coordinately Regulate Tissue-Specific Alternative Splicing In Vivo Mol. Cell. Biol., December 15, 2007; 27(24): 8612 - 8621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Paronetto, T. Achsel, A. Massiello, C. E. Chalfant, and C. Sette The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x J. Cell Biol., March 26, 2007; 176(7): 929 - 939. [Abstract] [Full Text] [PDF] |
||||
|
|